Australia’s Pharma Industry Urges No Cuts In PBS Spending
This article was originally published in PharmAsia News
Executive Summary
The head of Medicines Australia, which represents the pharmaceutical industry, urged the government to keep funding for the Pharmaceutical Benefits Scheme as it is, at $7 billion a year. Will Delaat, a cancer survivor, made the appeal as the government considers making budget cuts in the face of a faltering economy. Delaat said the government should quantify the areas of health spending before deciding which health programs to cut. Until the government has that information, he said, "don't jeopardize the integrity of the PBS." (Click here for more